Quantinuum (NASDAQ:QNT) Trading Down 6.1% – Time to Sell?

Quantinuum Inc. (NASDAQ:QNT) dropped 6.1% during trading on Thursday . The company traded as low as $66.77 and last traded at $67.35. 1,094,852 shares traded hands during mid-day trading, a decline of 59% from the average session volume of 2,668,238 shares. The stock had previously closed at $71.74.

Trending Headlines about Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Oracle partnership expands commercial reach: Quantinuum will deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure data center. The arrangement will let enterprise, academic and research customers access hybrid quantum-AI and high-performance-computing workloads through Oracle’s cloud without owning specialized hardware. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: Revenue and bookings showed momentum: Second-quarter revenue rose 279% year over year to $8 million, while analysts highlighted strong bookings and improving commercial adoption. Quantinuum also raised its fiscal 2026 revenue outlook to $28 million-$32 million, above the $26.6 million consensus estimate. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Analysts remain bullish: Rosenblatt reaffirmed a Buy rating with a $155 price target, while Needham maintained Buy at $100 and Cantor Fitzgerald reiterated Overweight with a $90 target. These targets imply substantial potential upside from recent trading levels. Analyst rating updates
• Neutral Sentiment: Technology milestones support the long-term story: Quantinuum said Helios demonstrated near five-nines logical fidelity, strengthening its positioning in fault-tolerant quantum computing. The company also announced a supply-chain collaboration with a major global electronics manufacturer. Quantinuum second-quarter results
• Negative Sentiment: Profitability remains a concern: Quantinuum reported an adjusted loss of $0.28 per share, missing the $0.26 consensus estimate. The loss widened even as revenue grew, and analysts expect the company to remain unprofitable for fiscal 2026. This may be prompting profit-taking after the initial post-earnings enthusiasm. Quantinuum Q2 2026 earnings

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on QNT. Zacks Research raised shares of Quantinuum to a “hold” rating in a research report on Tuesday, June 30th. Bank of America assumed coverage on shares of Quantinuum in a report on Monday, June 29th. They issued a “buy” rating and a $100.00 price objective for the company. JPMorgan Chase & Co. assumed coverage on shares of Quantinuum in a research report on Monday, June 29th. They set an “overweight” rating and a $97.00 target price on the stock. Craig Hallum began coverage on shares of Quantinuum in a research report on Monday, June 29th. They issued a “buy” rating and a $100.00 price target for the company. Finally, Mizuho started coverage on Quantinuum in a research note on Monday, June 29th. They issued an “outperform” rating and a $90.00 price target for the company. Ten analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $98.42.

Quantinuum Trading Down 5.0%

The stock has a 50-day moving average price of $62.89.

Quantinuum (NASDAQ:QNT) last released its earnings results on Tuesday, August 11th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.02). The business had revenue of $8.00 million for the quarter. Equities analysts predict that Quantinuum Inc. will post -1.61 earnings per share for the current fiscal year.

Insider Buying and Selling at Quantinuum

In other Quantinuum news, Director Kenneth D. Denman bought 14,000 shares of the business’s stock in a transaction on Friday, June 5th. The stock was purchased at an average cost of $60.00 per share, for a total transaction of $840,000.00. Following the completion of the purchase, the director directly owned 19,833 shares of the company’s stock, valued at approximately $1,189,980. This trade represents a 240.01% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Kevin Scott Dehoff bought 15,000 shares of Quantinuum stock in a transaction on Friday, June 5th. The stock was acquired at an average cost of $60.00 per share, for a total transaction of $900,000.00. Following the acquisition, the insider owned 126,460 shares in the company, valued at approximately $7,587,600. This represents a 13.46% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders acquired 411,032 shares of company stock valued at $24,661,920.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Quantinuum stock. Lisanti Capital Growth LLC purchased a new stake in Quantinuum Inc. (NASDAQ:QNT) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 5,005 shares of the company’s stock, valued at approximately $409,000.

Quantinuum Company Profile

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.